October 4, 2022


Merck Animal Health to acquire Vence



Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, announced on September 22 that it signed a definitive agreement under which the company will acquire Vence from its founders and shareholders.


Vence is an innovator in virtual fencing for rotational grazing and livestock management. The acquisition is expected to be completed in the third quarter of 2022, subject to customary closing conditions. Specific terms of the agreement were not disclosed.


Vence, a privately held company, provides enhanced technology for producers and ranchers to track, monitor and manage the movement of cattle through a high-tech platform of virtual fencing solutions.


Using a computer or smartphone, customers have the capability to manage cattle movement and facilitate rotational grazing. Vence's virtual fencing technology can reduce the need for fencing to subdivide pastures and allows producers and ranchers to manage their cattle and grass inventory, while reducing costs of labor and fencing materials.


"The acquisition of Vence will broaden our portfolio with complementary products and technologies to advance animal health and well-being as well as outcomes for our customers," said Rick DeLuca, president of Merck Animal Health. "Vence is a natural fit with Merck Animal Health's growing portfolio of animal intelligence products that include identification, traceability and monitoring products. This new technology will give cow-calf producers the ability to track their cattle and the ability to move them from pasture to pasture."


"I believe that Merck Animal Health is the best long-term home for this technology and our team," said Frank Wooten, founder and chief executive officer, Vence. "Their unparalleled expertise in the livestock space, ability to develop and scale hardware products, high-quality customer support and a strong global footprint to expand Vence's market reach make us really excited to join Merck Animal Health."


Vence's technology is currently available in the US and parts of Australia.   


- Merck Animal Health

Video >

Follow Us